Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kaitlin Woo"'
Autor:
Anita Kumar, Zhitao Ying, Anna Alperovich, Ahmet Dogan, Paul Hamlin, Craig Moskowitz, Janine Pichardo, Carol Portlock, Fushen Sha, Andrew D. Zelenetz, Zhigang Zhang, Esther Drill, Kaitlin Woo, Anas Younes
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Externí odkaz:
https://doaj.org/article/7041c7b043e94194abb8889066c22c80
Autor:
Spencer, Ryan, Alexander, Vinita, Eickhoff, Jens, Kaitlin Woo, Costanzo, Erin, Marx, Nick, Rose, Stephen
Publikováno v:
International Journal of Gynecological Cancer; Apr2020, Vol. 30 Issue 4, p525-532, 8p
Autor:
Stephen J. Schuster, Kaitlin Woo, Rosemarie Mick, Edward A. Stadtmauer, Sunita D. Nasta, Jakub Svoboda, Sarah J. Nagle
Publikováno v:
American Journal of Hematology. 88:890-894
Salvage chemotherapy followed by autologous stem cell transplant (ASCT) remains the current standard of care for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) with chemosensitive disease. The addition of rituximab results
Autor:
Samuel Swisher-McClure, Robert G. Uzzo, Nandita Mitra, Justin E. Bekelman, Kaitlin Woo, Marc C. Smaldone
Publikováno v:
International journal of radiation oncology, biology, physics. 89(1)
Purpose To examine recent practice patterns, using a large national cancer registry, to understand the extent to which dose-escalated external beam radiation therapy (EBRT) has been incorporated into routine clinical practice for men with prostate ca
Publikováno v:
Journal of cancer survivorship : research and practice. 8(2)
This study aimed to determine whether the Physical Activity and Lymphedema (PAL) trial weight training program for breast cancer survivors at risk of or with breast cancer-related lymphedema provided skeletal benefits.Of the 295 participants in the r
Autor:
Kaitlin Woo, Rosemarie Mick, Sunita D. Nasta, Jakub Svoboda, Sarah J. Nagle, Edward A. Stadtmauer, Stephen J. Schuster
Publikováno v:
Blood. 120:2689-2689
Abstract 2689 Salvage chemotherapy and autologous stem cell transplant (ASCT) remain the current standard of care for patients with diffuse large B-cell lymphoma (DLBCL) who have primary refractory disease or relapse after initial therapy. The additi
Publikováno v:
JTCVS Open, Vol 5, Iss , Pp 171-172 (2021)
Externí odkaz:
https://doaj.org/article/c386dcf8f92d4aae8acb6216ca6e08e7
Autor:
Ming-Ching Lee, Buitrago, Daniel H., Kyuichi Kadota, Ujiie, Hideki, Kaitlin Woo, Sima, Camelia S., Travis, William D., Jones, David R., Adusumilli, Prasad S.
Publikováno v:
OncoImmunology; Nov2014, Vol. 3 Issue 11, pN.PAG-N.PAG, 1p, 4 Charts, 3 Graphs